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Background: Diabetes mellitus (DM) is a chronic illness with impaired health-related 
quality of life and a high risk of psychiatric disorders. We carried out a systematic review 
analyzing the relationship between DM and suicide by providing a qualitative data 
synthesis of the studies.
Methods: We conducted, in accordance with Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses guidelines, a systematic search of the literature in PubMed, 
Scopus, ISI Web of Science, PsycINFO, Google Scholar, and ScienceDirect. Search 
terms were “suicid*” combined with the Boolean “AND” operator with “diabetes.”
Results: The initial search identified 568 citations. A total of 17 research reports met 
the predefined inclusion criteria and were analyzed. DM was found to be significantly 
associated with a marked increase in suicidal behaviors and suicidal ideation (SI), 
especially in patients with depressive symptoms. Insulin therapy, DM of long duration, 
and unsatisfactory glycemic control were identified as risk factors for SI in Type 1 (T1DM) 
and Type 2 (T2DM).
Conclusion: Health-care professionals need to be aware of the higher suicidal risk in 
patient subgroups based on the clinical characteristics of DM; thus, patients with these 
characteristics warrant special attention. In this regard, clinical management should 
include efforts to manage emotional distress in DM care.
Keywords: diabetes mellitus, suicidal behavior, suicidal ideation, suicide attempt, depression
inTRODUCTiOn
Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia resulting from defects 
in insulin secretion, insulin action, or both. The vast majority of cases of diabetes mellitus (DM) 
falls into two broad etiopathogenetic categories: Type 1 (T1DM) and Type 2 (T2DM) (1). DM is a 
complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strate-
gies beyond glycemic control (1) to maintain well-being and quality of life over time, to control risks, 
to manage disease symptoms, and to reduce the incidence of complications (2).
Patients with DM are at risk of physical and psychological complications. The short-term com-
plications include hypoglycemia, and the long-term complications include cardiovascular disease, 
neuropathy, nephropathy, and retinopathy.
The prevalence of depression and psychiatric diseases among adults with T1DM or T2DM is 
approximately double that observed in the general population (3, 4).
Depression has a negative impact on self-care (5) and has been shown to be related to poorer 
glycemic outcomes and therefore increased risk of complications (6).
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The presence of psychopathological symptoms, feeling of 
hopelessness, and fears of chronic nature of the disease may 
predispose the patient to the risk of suicidal ideations (SIs) and 
suicidal behavior, but also to neglect health care and lack motiva-
tion to adhere to the medical regimen (7). Suicide risk is consid-
ered a major psychiatric emergency in patients diagnosed with 
chronic illnesses (8). DM and particular aspects of living with 
DM are known to be associated with greater SI (9–12). Chung 
et al. found that DM was associated with a marked increase in 
suicidal behaviors (13).
There are few studies on suicidal risk factors in the patient 
with DM. The risk factors may be related to the patient’s char-
acteristics, such as coping skills, personality profile, additional 
psychiatric illness including depression and alcohol use, and the 
feeling of hopelessness. Other risk factors could be a family his-
tory of attempted suicide and completed suicide. This is raised 
by furthermore the chances of suicide are increased by illness-
related and situational risk factors such as adverse events, lack of 
social support, exacerbation of the illness, and gradual increase of 
DM complications. Another risk factor could be the easy access 
to means of self-harm by patients with DM (14).
Suicide is one of the highest public health priorities worldwide. 
The World Health Organization objectives for suicide prevention 
emphasize identification of high-risk groups (15).
Recognizing the clinical features associated with suicidal risk 
in patients with DM is crucial in order to realize screening and 
interventions aimed at prevention that should also take into 
account SI and suicidal behaviors.
In light of the above, the aim of this manuscript is to provide 
new insights for performing a systematic review by reporting the 
most relevant studies analyzing the clinical characteristics of the 
association between DM and suicide risk.
MATeRiALS AnD MeTHODS
eligibility Criteria
All papers published in English peer-reviewed journals focused 
on the presence of SI, attempted or committed suicide in 
patients with T1DM or T2DM with a medical diagnosis were 
included in the search. Where the title or abstract seems to 
describe a study eligible for inclusion, the full text was examined 
to consider its relevance on the basis of the inclusion criteria. 
Reviews, meta-analyses, commentaries, letters to the editor, 
books or book chapters, abstracts, and clearly irrelevant papers 
were excluded. We also excluded abstracts that did not relate to 
suicide and DM.
information Sources and Searches
This review was conducted using the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses guidelines (16). 
The research was carried out in October 2016 on an electronic 
database: Scopus, ISI Web of Science, PsycINFO, Google Scholar, 
ScienceDirect, and PubMed were used to identify published 
studies.
The following keywords were used: “diabetes” AND “suicid*” 
[Title/Abstract]. After the initial search was performed, the stud-
ies were screened for eligibility, duplicates were identified and 
discarded. The relevant studies were assessed using their titles 
and abstracts first and, finally, the full review of papers. Studies 
were discarded when the full text was not available. Results were 
not limited to chronological age of participants. Searching and 
eligibility of target responses were carried out independently by 
two investigators.
ReSULTS
Based both on inclusion and exclusion criteria, a total of 568 
original research studies were identified and selected for inclusion 
in the systematic review, as reported in the flowchart displayed 
in Figure 1. After removing the duplicates (N = 77) 491 papers 
remained. After that, reviews, meta-analyses, commentaries, let-
ters to the editor, books or book chapters, abstracts, non-English 
language, clearly irrelevant papers were eliminated (N =  471). 
Twenty full text articles were assessed for eligibility and were 
read and surveyed by all the authors. Three articles were excluded 
because they did not respect the eligibility criteria. At the end 
of this process of examination, 17 studies were included in the 
qualitative synthesis of the systematic review.
Medical Characteristics of Diabetic 
Patients with Suicide Risk
Studies conducted with diabetic patients have shown significant 
associations between suicidality and specific diabetes-related 
characteristics (see Table 1 for a detailed description of reviewed 
TABLe 1 | Distribution of the 17 relevant selected studies, including the reference, title, the population target, and the aims of the research.
Reference Title Population target and 
geographic location
Aims
Goldston et al. (7) Suicidal ideation (SI) and behavior and non-
compliance with the medical regimen among 
diabetic adolescents
N = 91
Patients with T1DM. United 
States
To examine the 1 year and lifetime prevalence of SI 
and suicidal behavior among adolescents with insulin-
dependent diabetes mellitus (DM)
Amer and Hamdan-
Mansour (8)
Psychosocial predictors of SI in patients 
diagnosed with chronic illnesses in Jordan
N = 442
Patients with T2DM. Jordan
To investigate the psychosocial predictors of SI among 
patients with chronic illnesses
Pompili et al. (9) Quality of life and suicide risk in patients with DM N = 100
Patients with T1DM or T2DM. 
Italy
To evaluate the perceived quality of life and its 
association with suicide risk in Italian patients with DM
Fuller-Thomson and 
Sawyer (10)
Lifetime prevalence of SI in a representative 
sample of Canadians with Type 1 diabetes
N = 190
Patients with T1DM. Canada
To compare the lifetime prevalence of SI among 
patients with and without T1DM
Ceretta et al. (11) Increased prevalence of mood disorders and SI 
in Type 2 diabetic patients
N = 996
Patients with T2DM. Brazil
To evaluate the association of mood disorders, SI, and 
the quality of life in patients with T2DM
Handley et al. (12) Research: educational and psychological issues 
SI reported by adults with Type 1 or Type 2 
diabetes: results from diabetes MILES-Australia
N = 3,338
Patients with T1DM or T2DM. 
Australia
To examine the prevalence and correlates of SI in a 
community-based sample of adults with DM
Chung et al. (13) SI and suicide attempts among DM: The Korea 
National Health and Nutrition Examination Survey 
from 2007 to 2012
N = 3,846
Patients with T1DM or T2DM. 
Republic of Korea
To evaluate the mental health of patients with DM 
and compared it with mental health in the general 
population
Lee et al. (17) Risk of SI in diabetes varies by diabetes regimen, 
diabetes duration, and HbA1c level
N = 9,159
Patients with T1DM or T2DM. 
South Korea
To investigate patient subgroups based on the clinical 
characteristics of DM to evaluate risk factors for SI
Roy et al. (18) Suicide attempts and ideation in African-
American type 1 diabetic patients
N = 725
Patients with T1DM. New 
Jersey
To examine suicidality and its correlates in T1DM 
and controls through a semi-structured interview on 
attempted suicide
Davis et al. (19) Risk of suicide in Australian adults with diabetes: 
the Fremantle Diabetes Study
N = 1,413
Patients with T1DM. Australia
To evaluate the risk of suicide in Australian adult with 
T1DM
Westling et al. (20) High CSF-insulin in violent suicide attempters N = 74
DM patients and MDD 
disorder. Sweden
To further clarify the role of insulin in patients with 
suicidal behavior
Löfman et al. (21) Characteristics of suicide among diabetes 
patients: a population-based study of suicide 
victims in Northern Finland
N = 2,489
Patients with T1DM or T2DM. 
Finland
To investigate insulin suicides among DM patients
Avci et al. (22) Suicide commitment with metformin: our 
experience with five cases
N = 5 cases
DM patients with metformin 
treatment. Turkey
To present five patients who used high doses of 
metformin for suicide attempt
Myers et al. (23) Brief report: depression and history of suicide 
attempts in adults with new-onset Type 2 
diabetes
N = 145
Patients with T2DM. United 
States
To assess past suicide attempts in a cohort of adults 
with T2DM diagnosed within the prior 24 months
Han et al. (24) Increased risk of SI in Korean adults with both 
diabetes and depression
N = 17.065
Patients with T1DM or T2DM. 
South Korea
To investigate the association between SI and DM in 
adults with and without depression
Radobuljac et al. (25) Lifetime prevalence of suicidal and self-injurious 
behaviors in a representative cohort of Slovenian 
adolescents with Type 1 diabetes
N = 126
Patients with T1DM. Slovenia
To determine lifetime prevalence of suicidal and 
self-injurious behaviors in adolescents with T1DM 
compared with healthy controls
Corathers et al. (26) Improving depression screening for adolescents 
with Type 1 diabetes
N = 528
Patients with T1DM. United 
States
To evaluate the prevalence of depressive symptoms 
and SI in a cohort of adolescents with T1DM
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studies). Amer and Hamdan-Mansour (8), by investigating the 
psychosocial predictors of SI in subjects affected by chronic 
diseases (T2DM, cardiovascular diseases and cancer), found 
the highest “seriousness” component among those with T2DM.
Lee et al. (17), in a sample of 9,159 South Korean adults aged 
40 years and over, observed a higher rate of SI in subjects with 
DM than in those without. The study also found an associa-
tion of SI with the insulin regimen, a longer duration of DM 
4Conti et al. DM and Suicide Risk
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(≥5 years) and a poorer glycemic control (HbA1c levels ≥ 6.5). 
Another Korean study (13) also reported a marked increase 
in SI and suicide attempts among participants classified as 
having DM in comparison with controls. Moreover, mental 
health problems (depressive mood for two or more continuous 
weeks, SI, and suicide attempts) increased in association with 
blood glucose levels.
By focusing on the T1DM population and the risk of suicide 
attempts, Roy et  al. (18) found that African-American T1DM 
patients were three to four times more likely to attempt suicide 
during their lifetime than subjects without DM. Davis and col-
leagues (19), by investigating the suicide risk and associated 
factors in an older diabetic Australian population, found also 
that if suicide is a rare event among diabetic adults, compared 
to the general population, a higher occurrence appeared in sub-
jects with T1DM and a greater diabetes-related disease burden. 
A bivariate comparison showed also a significant association 
between suicide with higher presence of retinopathy and greater 
antidepressant use.
Finally, a previous study (20) measured insulin concentra-
tion in cerebrospinal fluid in 74 suicide attempters. The higher 
cerebrospinal fluid-insulin level detected among patients with a 
violent suicide attempt than in those with a non-violent attempt, 
and a similar cerebrospinal fluid–insulin level measured in 
subjects with or without major depressive disorder, permitted to 
conclude that cerebrospinal fluid-insulin is involved in violent 
behavior but not in major depressive disorder.
Suicide Commitment with Antidiabetic 
Medications
To confirm the prevalence of T1DM and T2DM in the suicide 
population and to analyze the suicide method adopted, Löfman 
et  al. (21) conducted a study on a Finnish population. Of all 
suicide victims (n = 2,489) 3.1% had DM (T1DM = 34.6% and 
T2DM = 65.4%). Almost half of the T1DM victims chosen poison 
as the suicide method, and it was approximately twofold higher 
than victims without DM; also in T2DM, self-poisoning was 
more common compared to controls. Among T1DM victims, an 
insulin overdose was used by half of the self-poisoning cases (6 of 
13), whereas by only two patients in the T2DM group (13%) and 
none in the non-diabetic reference group. Furthermore, during 
suicide, half of the victims with T1DM were under the influence 
of alcohol which, taken excessively, could contribute to the risk 
of hypoglycemia.
Finally, Avci and colleagues (22) described five cases in which 
subjects attempted suicide with high doses of metformin, an oral 
anti-hyperglycemic drug that causes a lactate accumulation. The 
study also describes the interactions of metformin with other 
drugs or ethanol that could increase the risk of, or cause, lactic 
acidosis.
Suicide Risk and Mood Disorders in DM
Several studies have shown significant associations between 
DM, mood disorders, and suicidality (see Table 1 for a detailed 
description of reviewed studies).
In 2009, an Italian study conducted by Pompili et al. (9) observ-
ing a sample of 100 patients with T1DM and T2DM controlled 
for mood disorders found that patients with DM perceived a 
poor quality of life, which was related to low self-efficacy, high 
hopelessness, and suicidality.
In 2012, by focusing on a clinical sample consisting of 
patients with DM and mood disorders, Ceretta et  al. (11) 
demonstrated a high prevalence of depressive disorders, SI, 
and a poor quality of life in patients with T2DM receiving 
treatment with insulin.
Löfman and colleagues (21), using a sample of suicide victims, 
demonstrated the association between DM and suicide mediated 
by depression.
Myers et  al. (23) provided further evidence supporting the 
prevalence of suicidality and mood disorders in patients with 
DM by demonstrating that the rate of past suicide attempts in 
currently depressed patients with DM is 21.8%.
Han et  al. (24) investigated, in a large Korean sample, the 
presence of either DM or depression alone increased the likeli-
hood of SI significantly compared with the general population, 
by 1.6- and 5.7-fold, respectively. When both conditions were 
present, the odds of SI were increased more than sevenfold. 
There was, however, no significant difference in the odds of 
SI between those with depression only and those with both 
depression and DM after controlling for factors such as age, 
gender, and BMI (24).
These results were confirmed by Handley and colleagues in 
2015 (12) using a sample of patients with T1DM and T2DM. 
Particularly, the study showed that elevated rates of SI are largely 
accounted for by the presence of depressive symptoms, and social 
support was reported as a significant protective factor for idea-
tions of suicide in these patients.
In order to compare the prevalence of SI in the diabetic South 
Korean population with that in people without DM, Lee and 
colleagues (17) compared depressive symptoms, stress, SI, and 
associated factors using a chi-squared test. Depressive symptoms 
seemed to predict SI, while higher household income, higher 
education, and being married/cohabiting seemed to play a pro-
tective role.
Suicide Risk in Adolescents with DM
Goldston et al. (7) studied the prevalence of SI and suicidal behav-
ior among adolescents with DM in a sample of 91 outpatients. 
They found that the lifetime prevalence of SI in diabetic youths 
was 26.4% (n = 24 of 91), which appeared to be higher than the 
rates of the general population. Some clinical characteristics were 
associated to SI and suicidal behavior in adolescents with DM. 
The study, using the multivariate logistic model, showed that 
the duration of T1DM and the presence of psychiatric problems 
were related to SI in adolescent patients (7). Furthermore, the 
authors showed that SI during the previous year was related to 
non-compliance with medical treatment in 63.6% of the subjects; 
the authors also found that lifetime history of SI was strongly 
related to non-compliance with medical treatment in 62.5% of 
the subjects.
In 2009, a study conducted by Radobuljac et al. (25) found 
that adolescent females with DM reported a higher prevalence 
of SI compared to males (p < 0.001). The authors studied self-
injurious behavior in their sample of 126 patients and observed 
5Conti et al. DM and Suicide Risk
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that 38% of those who committed acts of self-harm used the 
manipulation of the treatment as a means of self-harm (inject-
ing higher doses of insulin to produce hypoglycemia or omitting 
insulin to produce hyperglycemia).
Corathers and colleagues (26), using a depression screening 
tool among patients 13–17 years of age, demonstrated that SI was 
endorsed in 7% of the sample assessed. In a previous study, Fuller-
Thomson and Sawyer (10) had already observed a higher lifetime 
prevalence of SI among adolescents and adults with T1DM 
compared to those without, even after adjustment for age and 
sex; they confirmed the necessity of a consistent screening for SI 
and depression to promote early identification and intervention 
in this population.
DiSCUSSiOn
Literature analysis has shown that the severity of DM can 
increase the risk of mental health disorders, such as depression 
and suicide risk. Suicide risk is a multifaceted issue that involves 
bio-psychosocial and cultural factors that interfere with the indi-
vidual abilities of patients. Taking the potential clinical implica-
tions related to suicide risk in diabetic patients, the present study 
is a review manuscript aimed at systematically investigating the 
published original research reports evaluating the emerging 
clinical links between DM and suicidal factors.
Despite limited and contrasting studies, DM per  se does 
not appear to be associated with SI and suicide. However, 
SI is more prominent among patients with DM than in those 
without [i.e., Ref. (11, 24, 26)], and this prevalence is associ-
ated with the depressive symptoms and the severity of illness, 
such as duration of DM, poor glycemic control, use of insulin 
treatment (17). In line with these results, a previous study in 
2012 (11) showed that patients with more comorbid conditions 
were more likely to report depressive disorders and SI versus 
individuals without DM. Chung et al. (13) further demonstrated 
that depressive mood, SI, and suicide attempts increased in 
association with blood glucose levels. Furthermore, in 2004, one 
study (20) measured insulin concentration in cerebrospinal fluid 
in 74 suicide attempters to clarify the role of insulin in major 
depressive disorder and violent suicide attempt and found that 
cerebrospinal fluid insulin is involved in violent behavior but not 
in major depressive disorder.
When taking into consideration, the duration of DM as 
a risk factor for suicide, several studies have investigated the 
incidence of suicidal behavior (i.e., ideation, attempts, and acts) 
among adults and elderly patients with T1DM (12, 19). Other 
studies have highlighted that T1DM patients were three to four 
times more likely to attempt suicide during their lifetime than 
subjects without DM (18) and that a higher occurrence appeared 
in subjects with T1DM and a greater diabetes-related disease 
burden (10, 19).
Chronic disease causes a major emotional impact, which 
appears most dangerous during adolescence. When focusing on 
adolescents with T1DM, a hopeless feeling regarding the illness 
might be associated with risk of suicide attempts, and also with 
neglect of health care and lack of motivation to adhere to medical 
instructions (25). The lifetime prevalence of SI in diabetic youths 
was 26.4% (7); among patients 13–17 years of age, it was demon-
strated that SI was endorsed in 7% of the sample assessed (26).
By focusing on clinical samples consisting of patients with 
DM and mood disorders, several studies evaluated the associa-
tion between suicidality and DM. Depressive symptoms were 
the most prominent predictor of SI in diabetic patients (17). 
Given the relationships between depression and suicidality, 
and between depression and DM, some studies examined the 
mediation role of depressive symptoms, finding that depression 
mediates the relationship between DM, suicide (21) and non-
compliant behavior with the medical regimen (17). In support 
of these findings, recent studies observed that the coexistence of 
DM and depression was associated with a much higher risk fac-
tor for SI (12, 23) and suicide attempts (13) than with DM alone. 
In fact, it has also been reported that subjects with an increased 
prevalence of endocrine abnormalities such as diabetes may be 
at increased risk of depression and/or anxiety disorders (27). 
Major depression is also correlated with well-known deficiency 
in serotonergic neurotransmission, as reported by Müller et al. 
(28). Neurotransmitter alterations and immune dysregulation 
lead to an increased generation of proinflammatory cytokines 
which play a crucial role in anxiety and depression (28, 29). 
It is interesting that patients with schizophrenia and other 
severe mental disorders have an increased risk of developing 
diabetes and hyperlipidemia and initiating medication for these 
diseases (30).
These findings are important, suggesting that the higher 
prevalence of suicidal risk observed among people with DM may 
be attributable to the increased prevalence of depressive symp-
toms. On the other hand, the study conducted by Pompili et al. 
(9), observing a sample of patients with DM controlled for mood 
disorders, found that patients with DM perceived a poor quality 
of life, which was related to low self-efficacy, high hopelessness, 
and suicidality. In other terms, the results indicate that DM is 
associated with an increased risk of suicide, independently from 
the severity of depressive condition (9).
According to Gois et  al. (31), depressive temperament may 
also be important to better understand the interplay between 
depression and diabetes.
Protective factors for suicidal risk were higher household 
income, higher education, social and emotional support (8, 
12), and marriage or cohabitation. Being single was a risk factor 
for suicide (17); furthermore, suicide risk includes also gender, 
developmental, and substance abuse determinants (18, 21, 23). 
Recent studies have raised concern on the role of insulin and 
other antidiabetic medication use as a suicide method in patients 
with DM (21, 22). Having the means close at hand to commit 
suicide can represent a major risk for these patients.
Understanding the clinical features that can lead the patient 
with DM to have SI or suicidal behavior is an important objective 
to identify patients at higher risk and to promote well-being and 
adhering to antidiabetic medication. The present review of the 
relevant literature supports the need for further investigation into 
the severity and nature of disabilities associated with DM and 
other chronic diseases (32) and their relationships with SI and 
suicidal behaviors. From the clinical point of view, when treating 
patients with DM, it is important to emphasize that only a very 
6Conti et al. DM and Suicide Risk
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These findings have implications for health-care profes-
sionals, pointing out the importance of adequate psychological 
screening and action plans for appropriate follow-up to reduce 
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